Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1997015281) USE OF AT LEAST ONE BETA-ADRENERGIC AGONIST AS A P SUBSTANCE ANTAGONIST
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1997/015281 International Application No.: PCT/FR1996/001530
Publication Date: 01.05.1997 International Filing Date: 01.10.1996
Chapter 2 Demand Filed: 28.04.1997
IPC:
A61K 31/137 (2006.01) ,A61K 31/44 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
13
Amines, e.g. amantadine
135
having aromatic rings, e.g. methadone
137
Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
Applicants:
L'OREAL [FR/FR]; 14, rue Royale F-75008 Paris, FR
Inventors:
BRETON, Michel; FR
DE LACHARRIERE, Olivier; FR
LECLAIRE, Jacques; FR
Agent:
TEZIER HERMAN, Béatrice; L'Oréal/D.P.I. 90, rue du Général-Roguet F-92583 Clichy Cédex, FR
Priority Data:
95/1244723.10.1995FR
Title (EN) USE OF AT LEAST ONE BETA-ADRENERGIC AGONIST AS A P SUBSTANCE ANTAGONIST
(FR) UTILISATION D'AU MOINS UN AGONISTE BETA-ADRENERGIQUE EN TANT QU'ANTAGONISTE DE SUBSTANCE P
Abstract:
(EN) The use of at least one $g(b)-adrenergic agonist as a P substance antagonist in a cosmetic composition or for preparing a pharmaceutical and particularly dermatological composition for treating disorders related to excessive P substance synthesis and/or release, is disclosed. A topical cosmetic or pharmaceutical composition including at least one $g(b)-adrenergic agonist, and a cosmetic treatment method for controlling pain caused by excessive P substance synthesis and/or release, or reducing the irritancy of a cosmetic composition, are also disclosed.
(FR) La présente invention concerne l'utilisation d'au moins un agoniste $g(b)-adrénergique dans une composition cosmétique en tant qu'antagoniste de substance P ou pour la préparation d'une composition pharmaceutique, plus particulièrement dermatologique, destinée à traiter les désordres associés à un excès de synthèse et/ou de libération de substance P. L'invention concerne également une composition cosmétique ou pharmaceutique, à usage topique, comprenant au moins un agoniste $g(b)-adrénergique et un procédé de traitement cosmétique en vue de diminuer la douleur liée à un excès de synthèse et/ou de libération de substance P ou de diminuer l'effet irritant d'une composition cosmétique.
Designated States: BR, CA, HU, JP, MX, NO, PL, RU
Publication Language: French (FR)
Filing Language: French (FR)
Also published as:
NO19976143MXPA/a/1997/010475EP0769293RU02169552JP2000503628 CA2222311
DE000069603681FR2740040DK0769293